Search JIM Advanced Search

Journal of Chinese Integrative Medicine ›› 2007, Vol. 5 ›› Issue (2): 122-125.doi: 10.3736/jcim20070203

Special Issue: Traditional Chinese Medicine

• Commentary • Previous Articles     Next Articles

Breast cancer pathogenesis of stagnation of phlegm, poison and blood stasis: rationale and clinical application in traditional Chinese medicine

Sheng Liu1, Yong-qiang Hua1, Zhen-ping Sun1, Song Tan2, De-ming Lu1   

  1. 1. Department of Breast Surgery, Longhua Hospital, Shanghai University of Traditional Chinese Medicine, Shanghai 200032, China
    2. Department of Oncology, Yantai Hospital of Traditional Chinese Medicine, Yantai, Shandong Province 265705, China
  • Online:2007-03-31 Published:2007-03-15

Breast cancer is called ''Ruyan'' in literature of traditional Chinese medicine. We synthesized the ancient and contemporary discussions and raised the theory that ''Duxie'' (poisonous pathogenic factor) is the etiological factor and pathologic product through the whole course of breast cancer. ''Liuyin Fudu'' (latent poison of six exogenous pathogenic factors) and ''Qiqing Yudu'' (stagnant poison of seven emotions) are the main etiological factors affecting the breast cancer occurrence. ''Aidu Neisheng'' (internal product of cancer poison) is the essential change in breast cancer occurrence. ''Tandu Yujie'' (stagnation of phlegm, poison and blood stasis) is the essential pathogenesis of the breast cancer's development. ''Yudu Weiqing'' (vestigial poison) is the main pathogenesis of breast cancer after operation. ''Yudu Pangcuan'' (vestigial poison invasion elsewhere) is the key pathogenesis of recurrence and metastasis after operation. ''Sanjie Jiedu'' (dispersing accumulation and detoxification) is an important therapeutic principle in breast cancer's treatment after operation. The ''Tandu-Yujie'' pathogenesis theory and ''Sanjie Jiedu'' therapeutic principle developed the theory about breast cancer in traditional Chinese medicine, and have some clinical application value.

Key words: breast cancer, pathogenesis, traditional Chinese medicine

CLC Number: 

  • R226
[1] 姜良铎, 张文生 . 从毒论治初探[J]. 北京中医药大学学报, 1998,21(5):2-3
Jiang LD, Zhang WS . Discussion of treatment based on poisonous pathogenic factors[J]. Beijing Zhong Yi Yao Da Xue Xue Bao, 1998,21(5):2-3
[2] 王文萍, 姜良铎, 刘明 . 肿瘤转移“痰毒流注”病机假说的研究思路[J]. 辽宁中医杂志, 2002,29(3):137-138
Wang WP, Jiang LD, Liu M . Research methods of ''Tandu Liuzhu'' pathogenesis hypojournal in tumor metastasis[J]. Liaoning Zhong Yi Za Zhi, 2002,29(3):137-138
[3] 张健, 张淑贤, 王沛 . 中医传舍理论与肿瘤转移[J]. 中国中医基础医学杂志, 1999,5(6):4-6
Zhang J, Zhang SX, Wang P . The traditional Chinese medicine doctrine of ''Chuanshe'' and tumor metastasis[J]. Zhongguo Zhong Yi Ji Chu Yi Xue Za Zhi, 1999,5(6):4-6
[4] 李俊玉 . 癌毒的病因病机及临证治法的概念探析[J]. 江西中医药, 2005,36(8):14-15
Li JY . Discussion on the ''Aidu'' definition of etiopathogenesis and pathogenesis and its treatment in clinical practice[J]. Jiangxi Zhong Yi Yao, 2005,36(8):14-15
[5] 吴雪卿, 阙华发, 何春梅 . 陆德铭教授治疗乳腺癌远处转移37例[J]. 上海中医药大学学报, 2000,14(1):24-26
Wu XQ, Que HF, He CM . 37 cases of remote metastasis of mammary carcinoma treated by Prof. Lu De-ming[J]. Shanghai Zhong Yi Yao Da Xue Xue Bao, 2000,14(1):24-26
[6] 陈前军, 司徒红林, 周劬志 , 等. 乳宁Ⅱ号抗乳腺癌短期复发转移的临床研究[J]. 现代中西医结合杂志, 2002,11(16):1546-1548
Cheng QJ, Situ HL, Zhou QZ , et al. Clinical research on prevention of short-term recidivation and metastasis of breast cancer by Runing Ⅱ[J]. Xian Dai Zhong Xi Yi Jie He Za Zhi, 2002,11(16):1546-1548
[7] 赵连臣, 贾喜花, 唐汉钧 . 乳宁Ⅱ号对乳腺癌术后患者生活质量影响的临床观察[J]. 中医药学刊, 2006,24(5):956-957
Zhao LC, Jia XH, Tang HJ . Clinical observation on life quality of the patients treated by Runing Ⅱ after operation of mammary cancer[J]. Zhong Yi Yao Xue Kan, 2006,24(5):956-957
[8] 秦海洸 . 唐汉钧教授治疗乳腺癌辨证思路与用药经验[J]. 中西医结合学报, 2004,2(4):297-298
Qin HG . Professor Tang Han-jun's thinking in syndrome differentiation and experience in treating breast cancer[J]. Zhong Xi Yi Jie He Xue Bao, 2004,2(4):297-298
[9] 唐汉钧, 高尚璞, 郑勇 , 等. 中医药治疗乳腺癌术后患者288例临床观察[J]. 上海中医药大学学报, 2002,16(3):23-25
Tang HJ, Gao SP, Zheng Y , et al. Clinical observation of 288 cases treated by Chinese medicine after surgery of mammary cancer[J]. Shanghai Zhong Yi Yao Da Xue Xue Bao, 2002,16(3):23-25
[10] 司徒红林, 林毅, 陈前军 , 等. 中药癌复康对乳腺癌术后化疗患者生存质量的影响[J]. 广州中医药大学学报, 2005,22(1):26-29
Situ HL, Lin Y, Chen QJ , et al. Effect of Aifukang on quality of life of breast cancer patients treated with chemotherapy after operation[J]. Guangzhou Zhong Yi Yao Da Xue Xue Bao, 2005,22(1):26-29
[11] 欧阳华强, 黄雯霞, 刘鲁明 , 等. 消瘕方治疗乳腺癌术后110例的临床观察[J]. 上海中医药杂志, 2006,40(6):50-51
Ouyang HQ, Huang WX, Liu LM , et al. Clinical observation of ''Xiaojia Decoction'' in treating postoperative mammary carcinoma in 110 cases[J]. Shanghai Zhong Yi Yao Za Zhi, 2006,40(6):50-51
[1] Wan-jun Guo, Yi Wang, Yu Deng, Lin-yan Cheng, Xin Liu, Ruo-fan Xi, Sheng-jie Zhu, Xin-yi Feng, Liang Hua, Kan Ze, Jian-yong Zhu, Dong-jie Guo, Fu-lun Li. Therapeutic effects of the extract of Sancao Formula, a Chinese herbal compound, on imiquimod-induced psoriasis via cysteine-rich protein 61. Journal of Integrative Medicine, 2022, 20(4): 376-384.
[2] Shang-jin Song, Xuan Liu, Qing Ji, Da-zhi Sun, Li-juan Xiu, Jing-yu Xu, Xiao-qiang Yue. Ziyin Huatan Recipe, a Chinese herbal compound, inhibits migration and invasion of gastric cancer by upregulating RUNX3 expression. Journal of Integrative Medicine, 2022, 20(4): 355-364.
[3] Marisa Casal. Improving the health and treatment success rates of in vitro fertilization patients with traditional chinese medicine: need for more robust evidence and innovative approaches. Journal of Integrative Medicine, 2022, 20(3): 187-192.
[4] Ning Guo, Fei Wu, Mei Wu, Yuan Wang, Qing Lang, Xiao Lin, Yi Feng. Progress in the design and quality control of placeboes for clinical trials of traditional Chinese medicine . Journal of Integrative Medicine, 2022, 20(3): 204-212.
[5] Yan-jun Lin, Kun-li Jiao, Bo Liu, Lu Fang, Shu Meng. Antiplatelet and myocardial protective effect of shexiang tongxin dropping pill in patients undergoing percutaneous coronary intervention: A randomized controlled trial. Journal of Integrative Medicine, 2022, 20(2): 126-134.
[6] Ofer Baranovitch, Meirav Wolff-Bar, Meora Feinmesser, Chen Sade-Zaltz, Ilan Tsarfaty, Victoria Neiman. Searching for the emotional roots of breast cancer: A cross-disciplinary analysis integrating psychology, Chinese medicine, and oncology biomarkers. Journal of Integrative Medicine, 2022, 20(1): 57-64.
[7] Jia-jia Li, Qing Liang, Guang-chun Sun. Traditional Chinese medicine for prevention and treatment of hepatocellular carcinoma: A focus on epithelial-mesenchymal transition. Journal of Integrative Medicine, 2021, 19(6): 469-477.
[8] Rui-jin Qiu, Min Li, Jia-yuan Hu, Jing Chen, Hong-cai Shang. Methods for development of a core outcome set for clinical trials integrating traditional Chinese medicine and Western medicine. Journal of Integrative Medicine, 2021, 19(5): 389-394.
[9] Mao-xing Pan, Chui-yang Zheng, Yuan-jun Deng, Kai-rui Tang, Huan Nie, Ji-qian Xie, Dong-dong Liu, Gui-fang Tu, Qin-he Yang, Yu-pei Zhang. Hepatic protective effects of Shenling Baizhu powder, a herbal compound, against inflammatory damage via TLR4/NLRP3 signalling pathway in rats with nonalcoholic fatty liver disease . Journal of Integrative Medicine, 2021, 19(5): 428-438.
[10] Ning Zhang, Xiao-he Xiao. Integrative medicine in the era of cancer immunotherapy: Challenges and opportunities. Journal of Integrative Medicine, 2021, 19(4): 291-294.
[11] Thomas Efferth, An-long Xu, Roxana Damiescu, Mita Banerjee, Norbert W. Paul, David Y.W. Lee. Can eastern wisdom resolve western epidemics? Traditional chinese medicine therapies and the opioid crisis. Journal of Integrative Medicine, 2021, 19(4): 295-299.
[12] Si-qi Tang, Yun-liang Wang, Zi-ye Xie, Yang Zhang, Yi Guo, Kang-li Gao, Tang-you Mao, Chun-e Xie, Jun-xiang Li, Xiao-yan Gao. Serum metabolic profiling of traditional Chinese medicine syndromes in patients with diarrhea-predominant irritable bowel syndrome. Journal of Integrative Medicine, 2021, 19(3): 274-281.
[13] Miao-yan Shi, Shi-qi Sun, Wei Zhang, Xing Zhang, Gui-hua Xu, Xuan Chen, Zi-jian Su, Xiu-ming Song, Lu-jiong Liu, Yi-bao Zhang, Yi-le Zhang, Meng Sun, Qi Chen, Yan Xue, Hua Lü, Wei-an Yuan, Xiao-rong Chen, Yun-fei Lu. Early therapeutic interventions of traditional Chinese medicine in COVID-19 patients: a retrospective cohort study. Journal of Integrative Medicine, 2021, 19(3): 226-231.
[14] Shu-jun Wei, Qing-man He, Qing Zhang, Kang-hua Fu, Ruo-lan Li, Wei Peng, Yong-xiang Gao. Traditional Chinese medicine is a useful and promising alternative strategy for treatment of Sjogren's syndrome: A review. Journal of Integrative Medicine, 2021, 19(3): 191-202.
[15] Yi Xia, Lu-shao-bo Shi, Jing-hui Chang, Hua-zhang Miao, Dong Wang. Impact of the COVID-19 pandemic on intention to use traditional Chinese medicine: A cross-sectional study based on the theory of planned behavior. Journal of Integrative Medicine, 2021, 19(3): 219-225.
Viewed
Full text


Abstract

Cited

  Shared   
  Discussed   
[1] Jin-rong Fu. Establishment of multivariate diagnosis and treatment system of modern gynecology of traditional Chinese medicine. Journal of Chinese Integrative Medicine, 2008, 6(1): 22-24
[2] Hao Li, Ming-jiang Yao, Wen-ming Zhao, Jie Guan, Lin-lin Cai, Ling Cui. A randomized, controlled, double-blind trial of Huannao Yicong capsule in senile patients with mild cognitive impairment. Journal of Chinese Integrative Medicine, 2008, 6(1): 25-31
[3] Zhi-chun Jin. Problems in establishing clinical guideline for integrated traditional Chinese and Western medicine. Journal of Chinese Integrative Medicine, 2008, 6(1): 5-8
[4] SUN Ming-yu, ZUO Jian, DUAN Ji-feng, HAN Jun, FAN Shi-ming, ZHANG Wei, ZHU Li-fang, YAO Ming-hui. Antitumor activities of kushen flavonoids in vivo and in vitro. Journal of Chinese Integrative Medicine, 2008, 6(1): 51-59
[5] Min Cheng, Qiong Feng, Shu-wen Qian, Hui Gao, Cui-qing Zhu. Preliminary assay of p-amyloid binding elements in heart-beneficial recipe. Journal of Chinese Integrative Medicine, 2008, 6(1): 68-72
[6] Ning-qun Wang, Liang-duo Jiang, Zong-xing Li. Research progress in asthma-related quality of life. Journal of Chinese Integrative Medicine, 2008, 6(1): 93-97
[7] Jing-yuan Mao, Chang-xiao Liu, Heng-he Wang, Guang-li Wei , Zhen-peng Zhang, Jie Xing, Wang Xian liang , Ying-fei Bi . Effects of Shenmai Injection on serum concentration and pharmacokinetics of digoxin in dogs with heart failure. Journal of Chinese Integrative Medicine, 2010, 8(11): 1070-1074
[8] Zhi-mei Wang, Bin Zhang. A study on translation of ellipses in Huangdi Neijing from perspective of hermeneutic theory. Journal of Chinese Integrative Medicine, 2010, 8(11): 1097-1100
[9] Gui Yu, Jie Wang. Thinking on building the network cardiovasology of Chinese medicine. Journal of Chinese Integrative Medicine, 2012, 10(11): 1206-1210
[10] Pedro Saganha João, Doenitz Christoph, Greten Tobias, Efferth Thomas, J. Greten Henry. Qigong therapy for physiotherapists suffering from burnout: a preliminary study. Journal of Chinese Integrative Medicine, 2012, 10(11): 1233-1239